Hyperglycemia, diabetes and stroke: Focus on the cerebrovasculature

Adviye Ergul, Weiguo Li, Mostafa M. Elgebaly, Askiel Bruno, Susan C. Fagan

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Acute ischemic stroke (AIS) results from the occlusion of an artery and causes vascular and neuronal damage, both of which affect the extent of ischemic injury and stroke outcome. Despite extensive efforts, there is only one effective treatment for AIS. Given that up to 40% of the AIS patients present with admission hyperglycemia either as a result of diabetes or acute stress response, targets for neuronal and vascular protection under hyperglycemic conditions need to be better defined. Here, we review the impact of diabetes and acute hyperglycemia on experimental stroke with an emphasis on cerebrovasculature structure and function. The relevance to clinical evidence is also discussed.

Original languageEnglish (US)
Pages (from-to)44-49
Number of pages6
JournalVascular Pharmacology
Volume51
Issue number1
DOIs
StatePublished - Jul 1 2009

Fingerprint

Hyperglycemia
Stroke
Blood Vessels
Arteries
Wounds and Injuries
Therapeutics

Keywords

  • Diabetes
  • Hyperglycemia
  • Ischemia reperfusion injury
  • Stroke

ASJC Scopus subject areas

  • Pharmacology
  • Molecular Medicine
  • Physiology

Cite this

Hyperglycemia, diabetes and stroke : Focus on the cerebrovasculature. / Ergul, Adviye; Li, Weiguo; Elgebaly, Mostafa M.; Bruno, Askiel; Fagan, Susan C.

In: Vascular Pharmacology, Vol. 51, No. 1, 01.07.2009, p. 44-49.

Research output: Contribution to journalArticle

Ergul, Adviye ; Li, Weiguo ; Elgebaly, Mostafa M. ; Bruno, Askiel ; Fagan, Susan C. / Hyperglycemia, diabetes and stroke : Focus on the cerebrovasculature. In: Vascular Pharmacology. 2009 ; Vol. 51, No. 1. pp. 44-49.
@article{43fe0e9317ad417aa257731b15c2033f,
title = "Hyperglycemia, diabetes and stroke: Focus on the cerebrovasculature",
abstract = "Acute ischemic stroke (AIS) results from the occlusion of an artery and causes vascular and neuronal damage, both of which affect the extent of ischemic injury and stroke outcome. Despite extensive efforts, there is only one effective treatment for AIS. Given that up to 40{\%} of the AIS patients present with admission hyperglycemia either as a result of diabetes or acute stress response, targets for neuronal and vascular protection under hyperglycemic conditions need to be better defined. Here, we review the impact of diabetes and acute hyperglycemia on experimental stroke with an emphasis on cerebrovasculature structure and function. The relevance to clinical evidence is also discussed.",
keywords = "Diabetes, Hyperglycemia, Ischemia reperfusion injury, Stroke",
author = "Adviye Ergul and Weiguo Li and Elgebaly, {Mostafa M.} and Askiel Bruno and Fagan, {Susan C.}",
year = "2009",
month = "7",
day = "1",
doi = "10.1016/j.vph.2009.02.004",
language = "English (US)",
volume = "51",
pages = "44--49",
journal = "Vascular Pharmacology",
issn = "1537-1891",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Hyperglycemia, diabetes and stroke

T2 - Focus on the cerebrovasculature

AU - Ergul, Adviye

AU - Li, Weiguo

AU - Elgebaly, Mostafa M.

AU - Bruno, Askiel

AU - Fagan, Susan C.

PY - 2009/7/1

Y1 - 2009/7/1

N2 - Acute ischemic stroke (AIS) results from the occlusion of an artery and causes vascular and neuronal damage, both of which affect the extent of ischemic injury and stroke outcome. Despite extensive efforts, there is only one effective treatment for AIS. Given that up to 40% of the AIS patients present with admission hyperglycemia either as a result of diabetes or acute stress response, targets for neuronal and vascular protection under hyperglycemic conditions need to be better defined. Here, we review the impact of diabetes and acute hyperglycemia on experimental stroke with an emphasis on cerebrovasculature structure and function. The relevance to clinical evidence is also discussed.

AB - Acute ischemic stroke (AIS) results from the occlusion of an artery and causes vascular and neuronal damage, both of which affect the extent of ischemic injury and stroke outcome. Despite extensive efforts, there is only one effective treatment for AIS. Given that up to 40% of the AIS patients present with admission hyperglycemia either as a result of diabetes or acute stress response, targets for neuronal and vascular protection under hyperglycemic conditions need to be better defined. Here, we review the impact of diabetes and acute hyperglycemia on experimental stroke with an emphasis on cerebrovasculature structure and function. The relevance to clinical evidence is also discussed.

KW - Diabetes

KW - Hyperglycemia

KW - Ischemia reperfusion injury

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=67349179497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349179497&partnerID=8YFLogxK

U2 - 10.1016/j.vph.2009.02.004

DO - 10.1016/j.vph.2009.02.004

M3 - Article

C2 - 19258053

AN - SCOPUS:67349179497

VL - 51

SP - 44

EP - 49

JO - Vascular Pharmacology

JF - Vascular Pharmacology

SN - 1537-1891

IS - 1

ER -